Cite
HARVARD Citation
Vazquez, J. et al. (n.d.). 992. Oral Ibrexafungerp Outcomes in Patients with Oropharyngeal and Esophageal Candidiasis from an Interim Analysis of a Phase 3 Open-label Study (FURI). Open forum infectious diseases. pp. S586-S587. [Online].